Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles

The use of doxorubicin (DOX), one of the most effective antitumor molecules in the treatment of metastatic breast cancer, is limited by its low tumor selectivity and its severe side effects. Colloidal carriers based on biodegradable poly(butylcyanoacrylate) nanoparticles (PBCA NPs) may enhance DOX a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Nanomedicine
Hlavní autoři: Cabeza, Laura, Ortiz, Raúl, Arias, José L, Prados, Jose, Ruiz Martínez, Maria Adolfina, Entrena, José M, Luque, Raquel, Melguizo, Consolación
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335619/
https://ncbi.nlm.nih.gov/pubmed/25709449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S74378
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky